Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA) [Phase 1, Phase 2]

View source ↗

Summary

Pilot multicenter, open-label trial evaluating how different doses of CBD and THC in a full-spectrum cannabis extract affect fibromyalgia symptoms. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Full-spectrum cannabis extract with CBD and THC (cannabis extract containing cannabidiol and tetrahydrocannabinol)

Snippet

Sponsor: Federal University of Latin American Integration | Conditions: Fibromyalgia | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING